ICU sedation, delirium & recovery

Venous thromboembolism in critically ill adult patients with hematologic malignancy: a population-based cohort study

Intensive Care MedPublished Population-based cohort study

Main finding · Incidence of VTEResult — go to the resultOdds ratio 3.08 95% CI 2.77–3.42

Authors' conclusion

Among patients with hematologic malignancy, critical illness and certain baseline characteristics were associated with a higher incidence of VTE.

Study context

Population
Hospitalised adults with a new diagnosis of hematologic malignancy, Ontario, Canada, 2006–2017
Participants
76,803 eligible patients
Exposure
Intensive care unit (ICU) vs non-ICU patients
  • ICUn = 20,524
Outcome
VTE (pulmonary embolism or deep venous thrombosis)

Main finding

Incidence of VTE

Odds ratio

3.08

95% CI 2.77–3.42

By group

ICU vs Non-ICU
OR 3.08 (95% CI 2.77–3.42)

As reported in the abstract

Association of critical illness and venous thromboembolism (VTE) remained significant after adjusting for potential confounders
OR 2.92; 95% CI 2.62-3.25

Observational data: associations, not effects.

Secondary outcomes

OutcomeICUNon-ICUOR (95% CI)
Incidence of major bleeding7.6%2.4%3.33 (3.09–3.58)

VTE by baseline characteristics

Higher incidence of VTE in patients with prior VTE
OR 6.64; 95% CI 5.42-8.14
Admission more than 1 year after diagnosis of hematologic malignancy associated with lower incidence of VTE
OR 0.64; 95% CI 0.56-0.74
Platelet count ≤ 50 × 109/L at the time of hospitalization associated with lower incidence of VTE
OR 0.63; 95% CI 0.48-0.84
Higher incidence of VTE among specific subtypes of hematologic malignancy

Safety

OutcomeICUNon-ICUOR (95% CI)
Major bleeding7.6%2.4%3.33 (3.09–3.58)

Original publication

Venous thromboembolism in critically ill adult patients with hematologic malignancy: a population-based cohort study. Intensive Care Med. Published 3 January 2024. doi:10.1007/s00134-023-07287-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.